8-K - Spyre Therapeutics, Inc. - 2.02 / 8.01
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001628280-26-024906
Filing Date: 2026-04-13
Accepted: 2026-04-13 16:29:22
Documents: 11
Period of Report: 2026-04-13
Items: Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events
Spyre Therapeutics, Inc. (Filer) CIK : 0001636282 (see all company filings) EIN. : 464312787 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 26858095 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | syre-20260413.htm iXBRL | 8-K
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | syre-20260413.xsd | EX-101.SCH
3 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | syre-20260413_lab.xml | EX-101.LAB
4 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | syre-20260413_pre.xml | EX-101.PRE